Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori Ferrins

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 7, 2015
6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei InhibitorsRaphaël Rahmani, Kung Ban, Amy J Jones, et al.
Journal of Medicinal Chemistry|July 1, 2014
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma bruceiLori Ferrins, Michelle Gazdik, Raphaël Rahmani, et al.
RSC Medicinal Chemistry|February 19, 2025
Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureasArthur Toynton, Lori Ferrins, Harriet L Newson, et al.
European Journal of Medicinal Chemistry|July 9, 2013
3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasisLori Ferrins, Raphaël Rahmani, Melissa L Sykes, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent <i>N</i>-Ethylurea Pyrazole Derivatives as Dual Inhibitors of <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i>Swapna Varghese, Raphaël Rahmani, Stephanie Russell, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Bioactivity Relationships of Lapatinib Derived Analogs against <i>Schistosoma mansoni</i>Melissa J Buskes, Monica Clements, Kelly A Bachovchin, et al.
Journal of Medicinal Chemistry|December 20, 2018
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug DevelopmentKelly A Bachovchin, Amrita Sharma, Seema Bag, et al.
Journal of Medicinal Chemistry|November 1, 2019
Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis TherapeuticsDana M Klug, Laura Tschiegg, Rosario Diaz, et al.
Cell Chemical Biology|February 16, 2021
Nuisance compounds in cellular assaysJayme L Dahlin, Douglas S Auld, Ina Rothenaigner, et al.
Plos Neglected Tropical Diseases|February 9, 2019
Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agentsDana M Klug, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 7, 2015
6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei InhibitorsRaphaël Rahmani, Kung Ban, Amy J Jones, et al.
Journal of Medicinal Chemistry|July 1, 2014
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma bruceiLori Ferrins, Michelle Gazdik, Raphaël Rahmani, et al.
RSC Medicinal Chemistry|February 19, 2025
Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureasArthur Toynton, Lori Ferrins, Harriet L Newson, et al.
European Journal of Medicinal Chemistry|July 9, 2013
3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasisLori Ferrins, Raphaël Rahmani, Melissa L Sykes, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent <i>N</i>-Ethylurea Pyrazole Derivatives as Dual Inhibitors of <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i>Swapna Varghese, Raphaël Rahmani, Stephanie Russell, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Bioactivity Relationships of Lapatinib Derived Analogs against <i>Schistosoma mansoni</i>Melissa J Buskes, Monica Clements, Kelly A Bachovchin, et al.
Journal of Medicinal Chemistry|December 20, 2018
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug DevelopmentKelly A Bachovchin, Amrita Sharma, Seema Bag, et al.
Journal of Medicinal Chemistry|November 1, 2019
Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis TherapeuticsDana M Klug, Laura Tschiegg, Rosario Diaz, et al.
Cell Chemical Biology|February 16, 2021
Nuisance compounds in cellular assaysJayme L Dahlin, Douglas S Auld, Ina Rothenaigner, et al.
Plos Neglected Tropical Diseases|February 9, 2019
Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agentsDana M Klug, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, et al.
Pageof 4